Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Arcus Biosciences Inc RCUS

Healthcare Biotechnology
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company involves in a portfolio of investigational products, which are in clinical development with its advanced molecule, an anti-TIGIT antibody targeting lung and gastrointestinal cancers. The Company has approximately seven clinical... see more

Recent & Breaking News (NYSE:RCUS)

Arcus Biosciences to Participate in the Bank of America Healthcare Conference 2024

Business Wire 3 hours ago

Arcus Biosciences to Present New Data from Phase 2 Studies of Novel Immuno-Oncology Combinations at the 2024 ASCO Annual Meeting

Business Wire 8 days ago

Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2024 Financial Results and Pipeline Update

Business Wire 9 days ago

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire April 9, 2024

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire March 26, 2024

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire March 11, 2024

Arcus Biosciences to Participate in Two Upcoming Investor Conferences

Business Wire February 28, 2024

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire February 27, 2024

Arcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Update

Business Wire February 21, 2024

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire February 9, 2024

Arcus Biosciences to Host Conference Call to Discuss Fourth-Quarter and Full-Year 2023 Financial Results and Pipeline Updates

Business Wire February 7, 2024

Gilead and Arcus Announce Amended Collaboration and Equity Investment

Business Wire January 29, 2024

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire January 26, 2024

Data from a Phase 1b Study of Quemliclustat-Based Regimens Showed Promising Overall Survival in Treatment-Naïve Metastatic Pancreatic Cancer

Business Wire January 16, 2024

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire December 11, 2023

Exelixis and Arcus Biosciences Announce Clinical Trial Collaboration to Evaluate Zanzalintinib in Combination with AB521 in Patients with Advanced Renal Cell Carcinoma

Business Wire December 4, 2023

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire November 27, 2023

Arcus Biosciences to Participate in the 6th Annual Evercore ISI HealthCONx Conference

Business Wire November 14, 2023

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire November 13, 2023

Arcus Biosciences Reports Third Quarter 2023 Financial Results and Provides a Pipeline Update

Business Wire November 7, 2023